Joint & Bone Health

Called bio+Quercitrin, the ingredient is said to be up to six times more bioavailable than standard quercetin.

Bioactive collagen peptides Fortigel from Gelita has been authorized by the National Health Agency (Anvisa) in Brazil to carry the claim “may contribute to the maintenance of joint health.”

Vedic Lifesciences, a contract research organization based, has completed a randomized, controlled dose response study for Interpath Pty Ltd. on its patented ingredient called Epiitalis.

An influx of next-generation ingredients and a growing consumer need are driving joint health supplements to new heights.

As consumers get active post-pandemic, they’ll find a wider range of sports supplements ready to cater to their every need.

The CRN Foundation has published a new economic report which analyzes the potential healthcare cost savings that could be realized if at-risk populations used specific dietary supplements as a form of preventative healthcare.

Kappa Bioscience (Oslo, Norway) has appointed John E. Repine, MD as the newest member of its “Blue Ribbon” Scientific and Medical Advisory Board.

The new Laboratory Guidance Document provides an evaluation of 46 analytical methods and their suitability to authenticate Boswellia serrata oleogum resin and its extracts.

ChenlandNutritionals’ ingredient CuminUP60 is now self-affirmed GRAS (generally recognized as safe) with assistance from GRAS Associates, a fully owned subsidiary of Nutrasource

Results showed that vitamin D supplementation did not have a significant impact on fracture risk. Industry advocates are criticizing the study's protocol.

At the center of these products is a unique species of algae, lithothamnion superpositum, which contains all 13-bone supporting minerals.

The company’s goal is to develop and optimize microorganisms in order to produce organic compounds such as proteins.

Ultimately, the study demonstrated that supplementation with krill was safe, and resulted in moderate improvements in knee pain, stiffness, and physical function.

The survey was conducted in 3500 dietary supplement consumers in the U.S., UK, Italy, Germany, and China.

In the study, 135 subjects with mild knee osteoarthritis received either 250 mg (50 mg curcuminoids) or 500 mg (100 mg curcuminoids) of Curcuwin Ultra+ per day for 84 days.

Results showed that subjects taking the extract were seeing significant improvements as early as five days into the trial, and post-trial, saw significant reductions of VAS, LFI, WOMAC pain, WOMAC stiffness, WOMAC function, and total WOMAC scores of 45%, 40.9%, 44.4%, 66.3%, 44.4%, and 48%, respectively.

Supplements only work if they are taken regularly. A smart system can help consumers reduce the mental load of their daily supplement routine.

The market researcher’s new 2022 mobility survey series so far shows that while some consumers understand that diet and nutrition support mobility, overall the nutrition, health, and supplements industry needs to get better at educating and encouraging consumers to adopt a proactive, long-term view of mobility health.

Results showed that compared to baseline, subjects saw significant reductions in pain and stiffness, as well as improvements in physical function.

The United States Patent and Trademark Office (USPTO) granted U.S. Patent No. 11,364,255 to Karallief Inc. for its Karallief Easy Climb, a multi-herbal extract formula for the support of joint discomfort.

Nutralliance has signed an agreement with Eggnovo to represent and market the company’s Ovoderm and Ovomet ingredients in the U.S.

The product is composed of a blend of standardized proprietary extracts of Cardio spermumhalicacabum, Boswellia serrata, Vitexne gundo, Bambusa arundinacea, Curcuma longa, and Citrus sinensis.

Balchem Corportation has signed a definitive agreement to acquire Kappa Bioscience AS, a manufacturer of K2Vital branded vitamin K2

According to Specnova, its ginger extract designed to support joint health, offers low dosage, high bioavailability, solubility, and stability.

A new study found ido-BRI, a cucumber-derived natural iminosugar amino acid and supplement ingredient, caused a dose-dependent reduction in the lipopolysaccharide(LPS)–induced production of three proinflammatory factors.